| ADALIMUMAB |
Yuflyma® |
CELLTRION HEALTHCARE AUSTRALIA PTY LTD |
Moderate to severe ulcerative colitis. Severe juvenile idiopathic arthritis. Severe
chronic plaque psoriasis. Severe Crohn disease. Vision-threatening non-infectious
uveitis |
Mar 2026 |
|
| ADALIMUMAB |
Amgevita® |
AMGEN AUSTRALIA PTY LIMITED |
Crohn disease. Ulcerative colitis. Active juvenile idiopathic arthritis. Complex refractory
fistulising Crohn disease. Active rheumatoid arthritis. Psoriatic arthritis. Ankylosing
spondylitis. Chronic plaque psoriasis. Hidradenitis suppurativa |
Mar 2026 |
|
| ADRENALINE (EPINEPHRINE) |
Neffy® |
SEQIRUS (AUSTRALIA) PTY LTD |
Acute allergic reaction with anaphylaxis |
Mar 2026 |
|
| ALECTINIB |
Alecensa® |
ROCHE PRODUCTS PTY LTD |
Non-small cell lung cancer (NSCLC) |
Mar 2026 |
|
| AMIVANTAMAB |
Rybrevant® |
JANSSEN-CILAG PTY LTD |
Non-small cell lung cancer (NSCLC) |
Mar 2026 |
|
| ASCIMINIB |
Scemblix® |
NOVARTIS PHARMACEUTICALS AUSTRALIA PTY LIMITED |
Chronic myeloid leukaemia (CML) |
Mar 2026 |
|
| AVACINCAPTAD PEGOL |
Izervay® |
ASTELLAS PHARMA AUSTRALIA PTY LTD |
Geographic atrophy (GA) secondary to age-related macular degeneration (AMD) |
Mar 2026 |
|
| BULEVIRTIDE |
Hepcludex® |
GILEAD SCIENCES PTY LTD |
Chronic hepatitis D |
Mar 2026 |
|
| CANAKINUMAB |
Ilaris® |
NOVARTIS PHARMACEUTICALS AUSTRALIA PTY LIMITED |
Colchicine-resistant or intolerant Familial Mediterranean Fever (crFMF) |
Mar 2026 |
|
| CANNABIDIOL |
Epidyolex® |
JAZZ PHARMACEUTICALS ANZ PTY LTD |
Severe myoclonic epilepsy in infancy (Dravet syndrome) |
Mar 2026 |
|
| CICLOSPORIN |
Vevye® |
AFT PHARMACEUTICALS (AU) PTY LTD |
Dry eye disease with keratitis |
Mar 2026 |
|
| DUPILUMAB |
Dupixent® |
SANOFI-AVENTIS AUSTRALIA PTY LTD |
Chronic obstructive pulmonary disease (COPD) |
Mar 2026 |
|
| DURVALUMAB |
Imfinzi® |
ASTRAZENECA PTY LTD |
Gastric cancer (GC) or gastro-oesophageal junction cancer (GOJC) |
Mar 2026 |
|
| EDARAVONE |
Radicava® |
TEVA PHARMA AUSTRALIA PTY LTD |
Amyotrophic lateral sclerosis (ALS) |
Mar 2026 |
|
| EFGARTIGIMOD ALFA |
Vyvgart® |
ARGENX AUSTRALIA PTY. LTD. |
Generalised myasthenia gravis (gMG) |
Mar 2026 |
|
| ENZALUTAMIDE |
Xtandi® |
ASTELLAS PHARMA AUSTRALIA PTY LTD |
Non-metastatic hormone sensitive prostate cancer (nmHSPC) |
Mar 2026 |
|
| GLYCOMACROPEPTIDE FORMULA WITH DOCOSAHEXAENOIC ACID AND LOW PHENYLALANINE |
PKU GMPro® Delight |
NUTRICIA AUSTRALIA PTY LIMITED |
Phenylketonuria (PKU) |
Mar 2026 |
|
| INCOBOTULINUM TOXIN A |
Xeomin® |
MERZ AUSTRALIA PTY LTD |
Moderate to severe spasticity of the lower limb in adults following an acute event |
Mar 2026 |
|
| INOTUZUMAB OZOGAMICIN |
Besponsa® |
PFIZER AUSTRALIA PTY LTD |
Acute lymphoblastic leukaemia (ALL) |
Mar 2026 |
|
| LANREOTIDE |
Lacreo® |
SUN PHARMA ANZ PTY LTD |
Acromegaly Functional carcinoid tumour. Non-functional gastroenteropancreatic neuroendocrine
tumour (GEP-NET). |
Mar 2026 |
|
| LONCASTUXIMAB TESIRINE |
Zynlonta® |
SWEDISH ORPHAN BIOVITRUM PTY LTD |
Diffuse large B-cell lymphoma (DLBCL) |
Mar 2026 |
|
| MEPOLIZUMAB |
Nucala® |
GLAXOSMITHKLINE AUSTRALIA PTY LTD |
Chronic obstructive pulmonary disease (COPD) |
Mar 2026 |
|
| NEMOLIZUMAB |
Nemluvio® |
GALDERMA AUSTRALIA PTY LTD |
Atopic dermatitis |
Mar 2026 |
|
| NIVOLUMAB |
Opdivo® |
BRISTOL-MYERS SQUIBB AUSTRALIA PTY LTD |
Malignant melanoma Non-Small Cell Lung Cancer (NSCLC). Renal Cell Carcinoma (RCC).
Squamous Cell Carcinoma of the Head and Neck (SCCHN). Urothelial Carcinoma (UC). Oesophageal
/ Gastro-oesophageal cancers(OC/GC). |
Mar 2026 |
|
| OBINUTUZUMAB |
Gazyva® |
ROCHE PRODUCTS PTY LTD |
Lupus nephritis |
Mar 2026 |
|
| ODEVIXIBAT |
Bylvay® |
IPSEN PTY LTD |
Alagille syndrome (ALGS) |
Mar 2026 |
|
| OMALIZUMAB |
Omlyclo® |
CELLTRION HEALTHCARE AUSTRALIA PTY LTD |
Uncontrolled severe asthma. Uncontrolled severe allergic asthma. Severe chronic spontaneous
urticaria. |
Mar 2026 |
|
| PEGCETACOPLAN |
Empaveli® |
SWEDISH ORPHAN BIOVITRUM PTY LTD |
Complement 3 glomerulopathy (C3G) or primary immune complex membranoproliferative
glomerulonephritis (IC-MPGN) |
Mar 2026 |
|
| PEGVALIASE |
Palynziq® |
BIOMARIN PHARMACEUTICAL AUSTRALIA PTY LTD |
Phenylketonuria (PKU) |
Mar 2026 |
|
| RESPIRATORY SYNCYTIAL VIRUS VACCINE |
Arexvy® |
GLAXOSMITHKLINE AUSTRALIA PTY LT |
Prevention of lower respiratory tract disease caused by respiratory syncytial virus
(RSV) |
Mar 2026 |
|
| RETIFANLIMAB |
Zynyz® |
SPECIALISED THERAPEUTICS ALIM PTY LTD |
Merkel cell carcinoma (MCC) |
Mar 2026 |
|
| RETIFANLIMAB |
Zynyz® |
SPECIALISED THERAPEUTICS ALIM PTY LTD |
Squamous cell anal carcinoma (SCAC) |
Mar 2026 |
|
| RILUZOLE |
Teglutik® |
ASTERI PHARMA PTY LTD |
Amyotrophic lateral sclerosis |
Mar 2026 |
|
| RISPERIDONE |
Uzedy® |
TEVA PHARMA AUSTRALIA PTY LTD |
Schizophrenia |
Mar 2026 |
|
| ROMIDEPSIN |
ROMIDEPSIN-REACH |
REACH PHARMACEUTICALS PTY LTD |
Relapsed or refractory peripheral T-cell lymphoma |
Mar 2026 |
|
| RUXOLITINIB |
Jakavi® |
NOVARTIS PHARMACEUTICALS AUSTRALIA PTY LIMITED |
Myelofibrosis Graft versus host disease Polycythemia vera |
Mar 2026 |
|
| SARS-COV-2 MRNA |
Spikevax® |
MODERNA AUSTRALIA PTY LTD |
Prevention of coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 |
Mar 2026 |
|
| SELPERCATINIB |
Retevmo® |
ELI LILLY AUSTRALIA PTY LTD |
Medullary thyroid cancer (MTC) |
Mar 2026 |
|
| TACROLIMUS |
aZematop® |
ARROTEX PHARMACEUTICALS PTY LTD |
Atopic dermatitis |
Mar 2026 |
|
| TAFAMIDIS |
Vyndamax® |
PFIZER AUSTRALIA PTY LTD |
Transthyretin amyloid cardiomyopathy (ATTR-CM) |
Mar 2026 |
|
| TAFASITAMAB |
Minjuvi® |
SPECIALISED THERAPEUTICS ALIM PTY LTD |
Relapsed and/or refractory follicular lymphoma (FL) |
Mar 2026 |
|
| TARLATAMAB |
Imdelltra® |
AMGEN AUSTRALIA PTY LIMITED |
Extensive-stage small cell lung cancer (ES-SCLC) |
Mar 2026 |
|
| TECLISTAMAB |
Tecvayli® |
JANSSEN-CILAG PTY LTD |
Relapsed or refractory multiple myeloma (RRMM) |
Mar 2026 |
|
| TILDRAKIZUMAB |
Ilumya® |
SUN PHARMA ANZ PTY LTD |
Severe chronic plaque psoriasis |
Mar 2026 |
|
| TIRZEPATIDE |
- Mounjaro®
- Mounjaro KwikPen®
|
ELI LILLY AUSTRALIA PTY LTD |
Type 2 diabetes mellitus (T2DM) |
Mar 2026 |
|
| TOFERSEN |
Qalsody® |
BIOGEN AUSTRALIA PTY LTD |
Amyotrophic lateral sclerosis (ALS) |
Mar 2026 |
|
| TRASTUZUMAB DERUXTECAN |
Enhertu® |
ASTRAZENECA PTY LTD |
Breast cancer |
Mar 2026 |
|
| UPADACITINIB |
Rinvoq® |
ABBVIE PTY LTD |
Fistulising Crohn’s disease (FCD) |
Mar 2026 |
|
| USTEKINUMAB |
Ardelya® |
SANDOZ PTY LTD |
Severe chronic plaque psoriasis. Severe psoriatic arthritis. |
Mar 2026 |
|
| VORASIDENIB |
Voranigo® |
SERVIER LABORATORIES (AUST.) PTY. LTD. |
Astrocytoma or oligodendroglioma |
Mar 2026 |
|